The one therapy obtainable for patients with leprechaunism to date is recombinant IGF1, aiming to prevent compensatory hyperinsulinemia (23). IGF has about the 6% from the glucose-reducing action result of insulin and it has an identical structure to it, for that reason it will be able to bind to insulin receptors triggering peripheral glucose upta… Read More